Table 2.
Patient Characteristics According to LSM and ELF Scores
|
LSM* <8.2 n = 158 |
LSM* ≥8.2 n = 72 |
P Value |
ELF Score <9.8 n = 180 |
ELF Score ≥9.8 n = 72 |
P Value | |
|---|---|---|---|---|---|---|
| Age† (years) | 57.0 (49.0‐66.0) | 59.5 (52.3‐66.0) | 0.505 | 55.0 (45.0‐63.0) | 65.0 (59.0‐72.0) | <0.001 |
| BMI† (kg/m2) | 31.3 (28.1‐35.9) | 37.5 (32.9‐42.8) | <0.001 | 32.5 (29.3‐38.3) | 36.0 (30.5‐41.4) | 0.031 |
| Girth‡ (cm) | 109.7 ± 15.3 | 127.8 ± 17.4 | <0.001 | 117.7 ± 17.5 | 122.3 ± 18.3 | 0.055 |
| T2DM,§ n (%) | 120 (75.9) | 67 (93.1) | 0.002 | 142 (78.9) | 66 (91.7) | 0.016 |
| HbA1C ≥7%,‖ n (%) | 80 (50.6) | 48 (66.7) | 0.031 | 102 (56.7) | 40 (55.6) | 0.872 |
| ALT† (IU/mL) | 29 (20‐48) | 43 (31‐64) | <0.001 | 32 (21‐52) | 33 (22‐57) | 0.658 |
| AST† (IU/mL) | 21 (16‐29) | 34 (22‐47) | <0.001 | 21 (15‐32) | 31 (18‐48) | <0.001 |
| GGT† (IU/mL) | 27 (19‐45) | 59 (38‐107) | <0.001 | 29 (20‐50) | 50 (25‐97) | <0.001 |
| Platelets‡ (× 109) | 254 ± 61 | 232 ± 69 | 0.016 | 254 ± 61 | 229 ± 68 | 0.004 |
| Albumin† (g/L) | 42 (40‐44) | 41 (38‐43) | 0.016 | 41 (39‐44) | 41 (36‐43) | 0.155 |
| ELF Score† | 8.9 (8.4‐9.5) | 9.9 (9.3‐10.5) | <0.001 | ‐ | ‐ | ‐ |
| ELF ≥ 9.8,‖ n (%) | 21 (13.3) | 39 (54.2) | <0.001 | ‐ | ‐ | ‐ |
| LSM† (kPa) | ‐ | ‐ | ‐ | 5.5 (4.6‐7.6) | 11.8 (4.2‐19.5) | <0.001 |
| LSM ≥ 8.2,‖ n (%) | ‐ | ‐ | ‐ | 33 (19.4) | 39 (65.0) | <0.001 |
*LSM data presented for 230 patients meeting quality criteria; †continuous data (median [IQR]) analyzed using Mann‐Whitney U Test; ‡continuous data (mean ± SD) analyzed using an independent t test; §categorical data analyzed using Fisher's exact test; ‖categorical data analyzed using Pearson's chi‐squared test.